Related Experiment Video
Updated: Sep 23, 2025

Oral Health Assessment by Lay Personnel for Older Adults
Published on: February 2, 2020
Oral and Swallowing Abilities Tool (OrSAT) in nusinersen treated patients
Beatrice Berti1, Lavinia Fanelli1, Giulia Stanca1
1Pediatric Neurology Unit and Centro Clinico Nemo, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Lazio, Italy.
Insights
Nusinersen treatment in infants with spinal muscular atrophy (SMA) shows promising results for swallowing function. Early intervention and assessment are key to predicting and improving swallowing abilities in these patients.
Area of Science:
- Neurology
- Pediatrics
- Genetics
Background:
- Type 1 spinal muscular atrophy (SMA) is a severe genetic neuromuscular disorder.
- Swallowing difficulties are a common and serious complication in SMA patients.
- Nusinersen is a targeted therapy for SMA.
Purpose of the Study:
- To longitudinally evaluate the swallowing capabilities of infants with type 1 SMA receiving nusinersen treatment.
- To identify factors influencing swallowing progression in treated SMA patients.
Main Methods:
- A cohort of 20 infants with type 1 SMA (mean age at treatment initiation: 3 weeks to 15 months) was studied.
- The Oral and Swallowing Abilities Tool (OrSAT) was used for swallowing assessment.
- Follow-up duration ranged from 12 to 62 months post-treatment initiation.
Main Results:
- 12/20 infants had normal swallowing at treatment start; 10 maintained this throughout follow-up.
- Two infants initially requiring tube feeding regained some oral intake.
- Of 8 infants with pre-existing tube feeding, 4 with tracheostomies showed no change, while 4 without tracheostomies demonstrated partial improvement.
Conclusions:
- The severity of functional impairment at the start of nusinersen treatment correlates with swallowing ability progression.
- Structured swallowing assessments like OrSAT can detect subtle functional improvements in SMA patients.
Introduction:
The aim of the study was to longitudinally assess swallowing abilities in nusinersen-treated patients with type 1 spinal muscular atrophy.
Methods:
Twenty infants with type 1 SMA (11 female and 9 male) treated with nusinersen between 3 weeks and 15 months of age, were assessed using the Oral and Swallowing Abilities Tool (OrSAT). The duration of the follow-up after treatment ranged between 12 months and 62 months.
Results:
Twelve of the 20 infants had normal swallowing and there was no need for tube feeding at the time treatment started. Ten of the 12 had consistently normal swallowing with no need for tube feeding on follow-up. The other two required tube feeding but they regained the ability to eat some food by mouth.The remaining 8 infants already had tube feeding inserted at the time treatment started: 4 of them also had tracheostomy and they showed no changes on the OrSAT Scale. The other 4 who had tube feeding but no tracheostomy had partial functional improvement.
Conclusion:
Our results suggest that the degree of functional impairment at the time treatment is started can help to predict the progression of swallowing abilities. The use of a structured assessment also helped to detect partial improvements.
More Related Videos
Related Concept Videos
Enteral Nutrition I: Orogastric and Nasogastric Feeding
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
Suctioning the Oropharyngeal Airway
After assembling the equipment, the nurse should practice hand hygiene and don appropriate PPE according to infection control guidelines to avoid the...
Assessment of the Mouth
Mouth Inspection
The inspection begins with visually examining the mouth for symmetry, color, and size.
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Deglutition
Swallowing can be divided into three stages: the voluntary phase, the pharyngeal phase, and the esophageal phase. Although the...

